Use of contraceptive depot medroxyprogesterone acetate is associated with impaired cervicovaginal mucosal integrity

BACKGROUND. Injectable depot medroxyprogesterone acetate (DMPA) is one of the most popular contraception methods in areas of high HIV seroprevalence. Evidence is accumulating that use of DMPA might be associated with an increased risk of HIV-1 acquisition by women; however, mechanisms of this associ...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Clin Invest
Hlavní autoři: Zalenskaya, Irina A., Chandra, Neelima, Yousefieh, Nazita, Fang, Xi, Adedipe, Oluwatosin E., Jackson, Suzanne S., Anderson, Sharon M., Mauck, Christine K., Schwartz, Jill L., Thurman, Andrea R., Doncel, Gustavo F.
Médium: Artigo
Jazyk:Inglês
Vydáno: American Society for Clinical Investigation 2018
Témata:
Clinical Medicine
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6159996/
https://ncbi.nlm.nih.gov/pubmed/30222141
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/JCI120583
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky